Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/09/045975
CTRI/2022/09/045975
Not yet recruiting
未知

Study of Nerve Conduction Parameters in Subjects with Type-II Diabetes Mellitus-A Cross Sectional study

Vandana Indraprakash Pattni0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Vandana Indraprakash Pattni
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
Vandana Indraprakash Pattni

Eligibility Criteria

Inclusion Criteria

  • •Subjects diagnosed with Type\-II Diabetes mellitus (as per WHO criteria)
  • •willing and capable of providing consent

Exclusion Criteria

  • •Subjects with type\-I Diabetes
  • •Chronic alcoholic
  • •cerebrovascular stroke
  • •peripheral neuropathy due to some other known cause
  • •peripheral arterial disease or evidence of limb ischemia
  • •subjects who refuse to give consent
  • •skin lesion or swelling which could interfere with Nerve conduction study
  • •trauma in the course of the nerve to be examined

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A Study of Nerve Conduction Velocity in various individuals of physical constitutions.
CTRI/2022/06/043541ATIONAL INSTITUTE OF AYURVEDA
Not yet recruiting
Not Applicable
A study of Nerve Conduction Velocity in Normal, Overweight and Obese Subjects.
CTRI/2024/06/068824Maulana Azad Medical College
Not yet recruiting
Not Applicable
Assess the nerve conduction velocity of ulnar nerve in NIA students in different body constitutio
CTRI/2024/04/065720ational institute of ayurveda jaipur
Recruiting
Not Applicable
Study comparing conduction in median nerve after treatment with Gabapentin or Amitriptyline in Diabetic patients suffering from neuropathic pain,and also comparing effectiveness and safety of both drugsHealth Condition 1: null- Daibetes mellitus with peripheral neuropathic pain
CTRI/2018/05/013750Government Medical College Patiala
Unknown
Not Applicable
A Validation Study of a Point-of-Care Nerve Conduction Device for the Prediction of Chemotherapy-induced Peripheral Neurotoxicity
JPRN-UMIN000017868Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital100